They are both administered as a once-weekly subcutaneous injection, but they have different FDA-approved indications and insurance coverage
With 92% of Americans considered metabolically unhealthy and GLP-1 use growing, the need for science-backed solutions has never been more urgent, said founding director Kim Fisher
Similar to the VTA, analysis of excitatory transmission shows that GLP-1r stimulation primarily changes presynaptic measures of release probability, again indicating a presynaptic GLP-1r localization(Mietlicki-Baase et al., 2014)
They can also cause rapid spikes in blood sugar and raise the risk of type 2 diabetes and heart disease
How We Approach Treatment At our clinic, we treat weight loss exclusively
Managing Age-Related Decline As people age, the natural production of growth hormone tends to decrease